Each pharmaceutical company should visually identify materials of promotional or non-promotional nature that may be provided to healthcare professionals as those which belong to non-prescription medicines. Here always chepest way to order meds in online drugstore in australia by visitng here. Simply when you need to purchase dramamine in australia. It may be best deal on the market. The ethical promotion of prescription medicines is vital to the pharmaceutical industry’s mission of helping patients by discovering, developing and marketing new medicines. Generic alternative of dramamine price is always reduced when ordered in online pharmacy. Especially in australia. The pharmaceutical industry has an obligation and responsibility to provide accurate information and education about its products to healthcare professionals in order to establish a clear understanding of the appropriate use of prescription medicines. Details about kamagra product line by Adjanta can be obtained on blog, you have chance to get kamagra online in uk. kamagra is one of the bestselling medicines online in uk. If you are seeking info for naltrexone ldn just navigate this.

National Lung Cancer Partnership is Now Free to Breathe, Continues Commitment to Double Five-Year Lung Cancer Survival By 2022

Posted by Samantha Powell on February 4th, 2014 |

News Headline: National Lung Cancer Partnership is Now Free to Breathe, Continues Commitment to Double Five-Year Lung Cancer Survival By 2022
Date: 2/4/14
Outlet Full Name: Sacramento Bee
Author: No author

MADISON, Wis., Feb. 4, 2014 — /PRNewswire-USNewswire/ — Changing its name – but not its focus – the National Lung Cancer Partnership is now Free to Breathe, a name that conveys the organization’s passion, dedication and vision to double lung cancer survival by 2022, empower advocates and help every person affected by the disease.

“Free to Breathe resonates deeply with people whose lives have been affected by lung cancer, and it embodies who we are and what we do,” said Joan H. Schiller, M.D., president of Free to Breathe and chief of hematology/oncology at the University of Texas Southwestern Medical Center, Dallas. “We believe that every lung cancer patient deserves a cure, and we will not rest until the movement reaches the critical mass necessary to make this a reality.”

People across the country are familiar with the name Free to Breathe, the long-time moniker for the organization’s nationwide fundraising and awareness event series, including walks, runs, bike rides and yogathons. Since it’s inception in 2006, the event series has raised more than $10 million with 100 percent of the net proceeds directly funding research and patient programs crucial to increasing survival. For information about upcoming events, visit www.freetobreathe.org/get-involved.

As Free to Breathe, the organization will continue its work towards the elimination of lung cancer, which claims more than 160,000 lives in the United States every year – more than any other cancer, and more than breast, colon and prostate cancers combined. Free to Breathe is committed to doubling survival by 2022 because the five-year lung cancer survival rate has increased only slightly in a decade, from 15 percent to 16 percent.

“Free to Breathe is an organization powered by people who are committed to forever changing what it means when a family faces a lung cancer diagnosis,” said Regina Vidaver, Ph.D., executive director of Free to Breathe. “Our programs, resources and events are poised to inspire and empower, propelling the movement like never before to double lung cancer survival.”

To double lung cancer survival by 2022, Free to Breathe focuses on accelerating research, helping patients understand treatment options and ensuring patients benefit from innovative therapies that save lives.

To learn more and become involved in Free to Breathe’s vision to double lung cancer survival visit www.freetobreathe.org

Free to Breathe

Free to Breathe, a 501(c)(3) non-profit organization, is a partnership of lung cancer survivors, advocates, researchers, healthcare professionals and industry leaders dedicated to doubling lung cancer survival by 2022. For more information, visit www.freetobreathe.org.

Comments are closed.